4//SEC Filing
Pichl Daniel 4
Accession 0001104659-24-025663
CIK 0001773427other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 6:56 PM ET
Size
9.1 KB
Accession
0001104659-24-025663
Insider Transaction Report
Form 4
Pichl Daniel
Chief People Officer
Transactions
- Exercise/Conversion
Common Stock
2024-02-16$27.64/sh+15,000$414,600→ 60,212 total - Sale
Common Stock
2024-02-16$50.10/sh−15,000$751,550→ 45,212 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-02-16−15,000→ 45,000 totalExercise: $27.64Exp: 2033-01-05→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]The transactions reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on March 9, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.35. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- [F3]This option shall vest in 48 equal monthly installments subject to continued service to the Issuer by the Reporting Person.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001819465
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 6:56 PM ET
- Size
- 9.1 KB